Product category:
Microbiology
News Release from: Warnex | Subject: Bioavailable testosterone testing
Edited by the Laboratorytalk Editorial
Team on 21 September 2007
Bioavailable testosterone testing
services deal
The bioavailable testosterone test is a diagnostic test recommended for male patients in evaluating a condition known as andropause
Warnex reports that its medical laboratories division has signed an agreement with Organon Canada, a biopharmaceutical company in Scarborough, Ontario, to provide bioavailable testosterone testing to customers across Canada "We are pleased to collaborate with Organon, a leader in the development of pharmaceutical products", said Mark Busgang, president and CEO of Warnex
This article was originally published on Laboratorytalk on 21 Mar 2006 at 8.00am (UK)
Related stories
Quantitative PCR test for food testing
Warnex has announced the launch of a quantitative test for Campylobacter for use with the real-time PCR-based Warnex rapid pathogen detection system
"Warnex uses a unique and very specific method for the detection of bioavailable testosterone.
"This agreement with Organon validates Warnex's strategy to focus on specialised medical testing aimed at niche markets".
The bioavailable testosterone test is a diagnostic test recommended for male patients in evaluating a condition known as andropause.
Andropause is caused by a decrease in hormone with age, which plays a direct role in various physiological changes, including muscle strength, bone density and body composition.
Warnex's test measures the amount of bioavailable testosterone, the biologically active form of testosterone, in human serum.
• Warnex: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
